首页> 外文期刊>Oncogene >The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma
【24h】

The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma

机译:候选肿瘤抑制基因BLU位于共同缺失区域3p21.3,是一种E2F调节的应激反应基因,并通过表观遗传和遗传机制在鼻咽癌中失活

获取原文
           

摘要

Loss of heterozygosity at 3p21 is common in various cancers including nasopharyngeal carcinoma (NPC). BLU is one of the candidate tumor suppressor genes (TSGs) in this region. Ectopic expression of BLU results in the inhibition of colony formation of cancer cells, suggesting that BLU is a tumor suppressor. We have identified a functional BLU promoter and found that it can be activated by environmental stresses such as heat shock, and is regulated by E2F. The promoter and first exon are located within a CpG island. BLU is highly expressed in testis and normal upper respiratory tract tissues including nasopharynx. However, in all seven NPC cell lines examined, BLU expression was downregulated and inversely correlated with promoter hypermethylation. Biallelic epigenetic inactivation of BLU was also observed in three cell lines. Hypermethylation was further detected in 19/29 (66%) of primary NPC tumors, but not in normal nasopharyngeal tissues. Treatment of NPC cell lines with 5-aza-2'-deoxycytidine activated BLU expression along with promoter demethylation. Although hypermethylation of RASSF1A, another TSG located immediately downstream of BLU, was detected in 20/27 (74%) of NPC tumors, no correlation between the hypermethylation of these two TSGs was observed (P=0.6334). In addition to methylation, homozygous deletion of BLU was found in 7/29 (24%) of tumors. Therefore, BLU is a stress-responsive gene, being disrupted in 83% (24/29) of NPC tumors by either epigenetic or genetic mechanisms. Our data are consistent with the interpretation that BLU is a TSG for NPC.
机译:3p21杂合性的丧失在包括鼻咽癌(NPC)在内的各种癌症中很常见。 BLU是该区域的候选肿瘤抑制基因(TSG)之一。 BLU的异位表达导致癌细胞集落形成的抑制,表明BLU是一种肿瘤抑制因子。我们已经鉴定出功能性的BLU启动子,并发现它可以被环境应力(如热激)激活,并受E2F调节。启动子和第一个外显子位于CpG岛内。 BLU在睾丸和正常的上呼吸道组织(包括鼻咽)中高表达。然而,在所有七个检查的NPC细胞系中,BLU表达均被下调,并且与启动子高度甲基化呈负相关。 BLU的双等位基因表观遗传失活还观察到了三种细胞系。在19/29(66%)的原发性NPC肿瘤中进一步检测到高甲基化,但在正常的鼻咽组织中未检测到。用5-氮杂-2'-脱氧胞苷处理NPC细胞系可激活BLU表达以及启动子去甲基化。尽管在20/27(74%)的NPC肿瘤中检测到RASSF1A(位于BLU紧下游的另一个TSG)的高甲基化,但未观察到这两个TSG的高甲基化之间的相关性(P = 0.6334)。除甲基化外,在7/29(24%)的肿瘤中发现了BLU的纯合缺失。因此,BLU是一种应激反应基因,在83%(24/29)的NPC肿瘤中被表观遗传或遗传机制破坏。我们的数据与BLU是NPC的TSG的解释一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号